Tuesday, April 10, 2012

Medical innovation kidneys

  • WASHINGTON, April 9 (Reuters) - Three experimental kidney devices may reach patients sooner under a plan from the U.S. Food and Drug Administration that would change the way the agency deals with medical innovation.
  • (Huffington Post)
  • GREENVILLE, S.C., April 9, 2012 /PRNewswire-USNewswire/ -- Greenville-based CreatiVasc Medical of the first Innovation Pathway, affects more than 571,000 Americans and is considered one of the most costly chronic diseases.
  • (PR Newswire)
  • that it had chosen three renal device projects to pilot a new regulatory approval program called Innovation Pathway 2.0, intended to bring breakthrough medical device technologies to patients faster and more efficiently.
  • (EurekAlert)
  • was organized by several medical societies to seek consensus on ways to increase the number of transplants made possible by paired donation and address ethical issues.
  • (New York Times)
  • Quest Diagnostics new renal monitoring test is an important medical innovation because it has the potential to improve patients lives while also helping to reduce the significant expense of failed kidney transplants.
  • (Boston Globe)
  • The hospital was cited for its industry leadership and clinical innovations first Kidney transplant in 1969; the first Liver transplant in 1983; and the birth of the first artificially conceived quadruplets in 1986.
  • (PR.com)

No comments:

Post a Comment